Min Hwan Kim

6PUBLICATIONS
71CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 01, 2026
Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer.

Jee Hyun Ahn, Ji Soo Park, Dongju Won

|Oct 02, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.

Hongsik Kim, Chiyoon Oum, Soo Ick Cho

|Aug 20, 2025
Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer.

Seung Hyuck Jeon, Koung Jin Suh, Sungmin Jung

|Dec 17, 2024
Low Skeletal Muscle Radiodensity Predicts Response to CDK4/6 Inhibitors Plus Aromatase Inhibitors in Advanced Breast Cancer.

Hyunwook Kim, Seungjin Baek, Sookyeong Han

|Nov 08, 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.

Yvette Drew, Jae-Weon Kim, Richard T Penson

|Jul 28, 2021
Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma.

Eunhyang Park, Jeong Eun Yoo, Ho Kyoung Hwang

Pageof 1

Frequent Collaborators

2 joint publications

Choong-Kun Lee

2 joint publications

Joohyuk Sohn

2 joint publications

Seock-Ah Im

1 joint publications

Eunhyang Park